pharmaphorum

JUNE 27, 2022

The bolt-on deal comes shortly after Ipsen announced plans to sell its consumer health business for around €350 million, leaving it as a pure-play prescription pharma operating in the cancer, rare diseases and neuroscience categories. Ipsen is offering $1.45 Ipsen’s CVR offer includes $0.30

Biopharma 83

Biopharma Sales Prescription FDA 83

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. CMS negotiation may lead to additional savings for beneficiaries and for the Medicare program.

Manufacturing 111

Manufacturing Competition Marketing Physicians 111

Pharmaceutical Technology

AUGUST 22, 2022

Softgels have now achieved strong recognition in the prescription, consumer health and supplements markets. If the doses can be combined, this decreases the burden on the patient and reduces prescription problems. billion by 2028, at a CAGR of 12.6%. This makes them ideal for patient groups such as children and seniors.

Prescription 52

Prescription Safety Patients Pharmaceutical 52

PM360

SEPTEMBER 21, 2023

This product would be a more potent prescription version than the OTCs, Casberg notes. This increases to 15 Part D drugs in 2026, as well as 15 Part B and D drugs in 2028, and a full 20 Part B and D drugs in 2029. The impact of the IRA’s price negotiations on payers is mixed, he noted.

Management 105

Management Manufacturing Sales Competition 105

Clarivate

APRIL 18, 2024

RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. In classic Amazon style, its pharmacy offers two-day shipping on prescriptions by mail, with same-day delivery available in seven markets, with plans to add a dozen more cities by year end.

Retail 52

Retail Healthcare Healthcare Physicians 52

Nixon Gwilt Law

MAY 26, 2023

The following Category III CPT codes are effective as of January 1, 2023, and are set to expire January 1, 2028, unless each code is individually modified to extend its expiration date or provide permanent payment. For information on how Nixon Gwilt helps DTx companies, click here.

Healthcare 119

Healthcare Healthcare Marketing Healthcare Provider 119

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. The facts: All Part D beneficiaries will pay $0 out of pocket for prescriptions in the catastrophic phase. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law.

Government 97

Government Manufacturing Prescription Competition 97

World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. Still, the pharma industry is fighting hard to keep it off the table.

Pharma 256

Pharma Prescription Manufacturing Insurance 256

World of DTC Marketing

APRIL 7, 2022

By 2028, these costs are expected to climb to $6.2 While the media is focused on drug costs, which are a problem, only 12% of every healthcare dollar is spent on prescription drugs. In the Netherlands, only 12 percent of women said they had forgone care for cost reasons. THREAT 3: RISING HEALTHCARE COSTS. A study reported that U.S.

Healthcare 215

Healthcare Healthcare Food and Drug Administration Government 215